Abstract:The reduction of excessive weight remains a major public health challenge, with control currently limited to a calorie reduction strategy. Currently, attempts are being made at revisiting the fibre hypothesis based on the African studies of Denis Burkitt, that the lack of dietary fibre in the modern diet was responsible for the occurrence of obesity and many of the other non-communicable diseases of what he called “Western civilization”. However, the dilemma is that Burkitt himself stressed that other peoples of his day, such as the Maasai, remained healthy without consuming such high fibre diets. Equally, the present obesity epidemic is accompanied by diseases of a malfunctioning immune system and of poor mental health that do not seem to be adequately explained simply by a deficiency of dietary fibre. Though unknown in Burkitt’s day, an increasing degradation of a mutualistic intestinal microbiome would offer a better fit to the observed epidemiology, especially if the microbiome is not effectively passed on from mother to child at birth. Taking the broader view, in this article we posit a view of the microbiome as a cofactor of mammalian evolution, in which a maternal microbial inheritance complements the parental genetic inheritance of the animal, both engaging epigenetic processes. As this would require the microbiome to be fully integrated with the animal as it develops into an adult, so we have a meaningful evolutionary role for the microbiome–gut–brain axis. By a failure to correctly establish a microbiome–gut interface, the inhibition of maternal microbial inheritance sets the scene for the future development of non-communicable disease: compromised immune system function on the one hand and dysfunctional gut–brain communication on the other. The basic principle is that the fully functioning, diverse, microbiome achieves interkingdom communication by the generation of messenger chemicals, semiochemicals. It is envisaged that the in situ detection of these as yet ill-defined chemical entities by means of an ingestible sensor would indicate the severity of disease and provide a guide as to its amelioration.

Macro insights into the shared and distinct regulations of dietary polysaccharides on gut microbiota and their roles in obesity

Dietary Fiber and Its Potential Role in Obesity: A Focus on Modulating the Gut Microbiota

The Influence of Polysaccharides on Lipid Metabolism: Insights from Gut Microbiota

Microbiome–Gut Dissociation: Investigating the Origins of Obesity

The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: A review

The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

The regulation of glucose and lipid metabolism through the interaction of dietary polyphenols and polysaccharides via the gut microbiota pathway

Dietary plants, gut microbiota, and obesity: Effects and mechanisms

The Role of Gut Microbiota Modulation Strategies in Obesity: The Applications and Mechanisms

Integrative analysis reveals the anti-obesity roles of Poria cocos polysaccharides through beneficial effects on gut microbiota

Extraction, purification, structural characterization, and gut microbiota relationship of polysaccharides: A review

Recent advances in the extraction, purification, structural-property correlations, and antiobesity mechanism of traditional Chinese medicine-derived polysaccharides: a review

The critical role of gut microbiota in obesity

Gut microbial metabolite short-chain fatty acids and obesity

Effects of dietary fibre on metabolic health and obesity

Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

An overview of traditional Chinese medicine affecting gut microbiota in obesity

Lipid metabolism regulation by dietary polysaccharides with different structural properties

Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases